The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 31, 2021
Filed:
Aug. 26, 2016
Applicant:
Debiopharm International, S.a., Lausanne, CH;
Inventors:
Jutta Deckert, Lexington, MA (US);
Daniel Tavares, Natick, MA (US);
Lingyun Rui, Weston, MA (US);
Sven Loebrich, Waltham, MA (US);
Meghan Puopolo, Burlington, MA (US);
Assignee:
DEBIOPHARM INTERNATIONAL, S.A., Lausanne, CH;
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 16/30 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2896 (2013.01); C07K 16/30 (2013.01); G01N 33/574 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/54 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/569 (2013.01); C07K 2317/622 (2013.01); C07K 2317/624 (2013.01); C07K 2317/626 (2013.01); C07K 2317/92 (2013.01); G01N 2333/70596 (2013.01);
Abstract
The invention generally relates to antibodies that bind to human CD37 and diagnostic assays for CD37-based therapies.